Encompass Health (NYSE:EHC – Get Free Report) released its earnings results on Thursday. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12, Zacks reports. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. Encompass Health updated its FY 2025 guidance to 4.670-4.960 EPS.
Encompass Health Stock Up 1.3 %
Encompass Health stock opened at $99.86 on Friday. Encompass Health has a fifty-two week low of $72.37 and a fifty-two week high of $104.55. The company has a market cap of $10.06 billion, a PE ratio of 22.39, a PEG ratio of 1.18 and a beta of 0.90. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The business’s 50-day simple moving average is $96.28 and its two-hundred day simple moving average is $95.19.
Analyst Ratings Changes
Several research firms have commented on EHC. Truist Financial restated a “buy” rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Barclays upped their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday. William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Friday. Royal Bank of Canada upped their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, KeyCorp lifted their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $107.33.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Stories
- Five stocks we like better than Encompass Health
- What is an Earnings Surprise?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- What is MarketRank™? How to Use it
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- How to Calculate Return on Investment (ROI)
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.